| Income statement (USD) | Q2 2026 ended Jun 30, 2026 | Q1 2026 ended Mar 31, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 30, 2025 | Q2 2025 ended Jun 30, 2025 | Q1 2025 ended Mar 31, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.36B | 5.32B | 5.23B | 5.13B | 5.11B | 4.91B | 4.95B | 5.03B |
| Cost of revenue | 2.06B | 2.10B | 2.08B | 2.08B | 2.04B | 1.92B | 1.96B | 1.96B |
| Gross profit | 3.30B | 3.23B | 3.15B | 3.05B | 3.07B | 2.99B | 2.98B | 3.07B |
| Selling, general and admin | 2.13B | 2.08B | 2.07B | 1.97B | 1.96B | 1.90B | 1.90B | 1.98B |
| Operating income | 1.02B | 964.00M | 92.00M | 1.06B | 1.08B | 1.08B | 1.06B | 1.06B |
| EBITDA | 1.17B | 1.12B | 265.00M | 1.22B | 1.23B | 1.22B | 1.21B | 1.22B |
| Interest expense | 62.00M | 62.00M | 64.00M | 67.00M | 71.00M | 66.00M | 66.00M | 74.00M |
| Income before tax | 950.00M | 892.00M | 108.00M | 992.00M | 1.01B | 953.00M | 993.00M | 986.00M |
| Income tax | 231.00M | 211.00M | 113.00M | 226.00M | 234.00M | 227.00M | 214.00M | 210.00M |
| Net income | 693.00M | 646.00M | -37.00M | 735.00M | 743.00M | 690.00M | 739.00M | 737.00M |
| EPS | 0.87 | 0.81 | -0.04 | 0.91 | 0.92 | 0.85 | 0.91 | 0.90 |
| EPS (diluted) | 0.86 | 0.80 | -0.04 | 0.91 | 0.91 | 0.85 | 0.90 | 0.90 |
| Diluted shares | 801.80M | 805.10M | -1.70M | 810.20M | 813.30M | 815.00M | -1.00M | 822.50M |
| Dividends per share | 0.53 | 0.53 | 0.52 | 0.52 | 0.52 | 0.52 | 0.50 | 0.50 |
From Colgate-Palmolive's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.